A phase III study of Aviptadil in sarcoidosis

Trial Profile

A phase III study of Aviptadil in sarcoidosis

Phase of Trial: Phase III

Latest Information Update: 06 Oct 2016

At a glance

  • Drugs Aviptadil (Primary)
  • Indications Pulmonary sarcoidosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Oct 2016 According to a Relief Therapeutics media release, European regulators have indicated that a single pivotal Phase III trial would be sufficient to support approval.
    • 29 Jul 2016 New trial record
    • 27 Jul 2016 According to Relief Therapeutics media release, top-line data is expected in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top